Enzymatica AB (publ) operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enzymatica AB (publ) with three other
pharmaceutical manufacturers in Europe:
Mithra Pharmaceuticals SA
sales of 9.03 million Euros [US$10.85 million]
of which 60%
Arcticzymes Technologies ASA
(93.45 million Norwegian Kroner [US$11.21 million]
based in FRANCE
(9.83 million Euros [US$11.81 million]
of which 100%
was immunotherapy products).
During the year ended December of 2020, sales at
Enzymatica AB (publ) were SEK 111.25 million (US$13.11 million).
increase of 81.5%
versus 2019, when the company's sales were SEK 61.31 million.